Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer

2004 ◽  
Vol 49 (3) ◽  
pp. 259-263 ◽  
Author(s):  
L Gallelli ◽  
M Nardi ◽  
T Prantera ◽  
S Barbera ◽  
M Raffaele ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Retrospective Analysis ◽  
Adverse Drug Reactions ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Drug Reactions ◽  
Small Cell Lung ◽  
Gemcitabine Treatment

miRNAs as biomarkers of adverse drug reactions to platinum-based agents in patients with non-small-cell lung cancer

2021 ◽  
Vol 15 (13) ◽  
pp. 1067-1069
Author(s):  
Pedro ENS Vasconcelos ◽  
Marília B Visacri ◽  
Eder de C Pincinato ◽  
Nadine de G Torso ◽  
Cecília S Seguin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Adverse Drug Reactions ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Drug Reactions ◽  
Small Cell Lung

scholarly journals Analysis of Adverse Drug Reactions on Osimertinib in T790M-Positive EGFR-Mutant Non-Small Cell Lung Cancer

2018 ◽  
Vol 44 (7) ◽  
pp. 355-362
Author(s):  
Shinji Tagawa ◽  
Ryosuke Kajiwara ◽  
Kimitaka Suetsugu ◽  
Toshikazu Tsuji ◽  
Hiroyuki Watanabe ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Adverse Drug Reactions ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Drug Reactions ◽  
Small Cell Lung ◽  
Egfr Mutant

scholarly journals PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation

2020 ◽  
Vol 8 (5) ◽  
pp. 1418-1430 ◽  
Author(s):  
Tiankuan Li ◽  
Zhongqian Hu ◽  
Chao Wang ◽  
Jian Yang ◽  
Chuhui Zeng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Synergistic Effect ◽  
Small Cell Lung Cancer ◽  
Adverse Drug Reactions ◽  
Checkpoint Inhibitor ◽  
Ultrasound Irradiation ◽  
Small Cell ◽  
Drug Reactions ◽  
Small Cell Lung ◽  
Targeted Microbubbles

Immunotherapy is gradually becoming as important as traditional therapy in the treatment of cancer, but adverse drug reactions limit patient benefits from PD1/PD-L1 checkpoint inhibitor drugs in the treatment of non-small cell lung cancer (NSCLC).

scholarly journals Retrospective Analysis of Re-Challenge of EGFR TK-IS in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer

2013 ◽  
Vol 24 ◽  
pp. ix96
Author(s):  
R. Yoshino ◽  
Y. Tomizawa ◽  
K. Takei ◽  
T. Kuwako ◽  
A. Yoshii ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Retrospective Analysis ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document